C4 Therapeutics
C4 Therapeutics is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies to treat cancer and other diseases. Utilizing its proprietary TORPEDO® platform, C4 Therapeutics designs small-molecule medicines that harness the body’s natural protein degradation mechanisms to selectively eliminate disease-causing proteins. The company’s innovative approach aims to address unmet medical needs by targeting proteins previously considered undruggable. With a robust pipeline of investigational therapies, C4 Therapeutics is committed to advancing novel treatments that have the potential to transform patient care. The company collaborates with leading industry partners to accelerate the development of its protein degradation therapeutics and drive scientific innovation in the field.
